Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Chi Chen

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Dermatology|November 17, 2024
Response to Truel J. et al's "Response to 'Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia'"Li-Chi Chen, Aubrey Martin, Maryanne M Senna
Archives of Dermatological Research|July 5, 2024
Top 20 dermatologic conditions affecting adult patients of color in the United States: insights from an All of Us Database analysisLi-Chi Chen, Sharon Kam, Hye Jin Chung
Cells|October 23, 2021
Modulation of Inherent Niches in 3D Multicellular MSC Spheroids Reconfigures Metabolism and Enhances Therapeutic PotentialLi-Chi Chen, Hsin-Wen Wang, Chieh-Cheng Huang
World Journal of Psychiatry|December 26, 2014
Polydipsia, hyponatremia and rhabdomyolysis in schizophrenia: A case reportLi-Chi Chen, Ya-Mei Bai, Meng-Han Chang
Journal of the American Academy of Dermatology|February 2, 2025
Discrepancies in patch testing timing and outcomes: A retrospective analysis of the Pediatric Allergic Contact Dermatitis RegistryMykayla Sandler, Eun Jae Kim, Li-Chi Chen, et al.
Journal of the American Academy of Dermatology|October 23, 2024
5α-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort studyLi-Chi Chen, Tina Yi Jin Hsieh, Maryanne M Senna
Journal of the American Academy of Dermatology|February 4, 2024
Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopeciaLi-Chi Chen, Chino Ogbutor, Kristen J Kelley, et al.
Skin Appendage Disorders|June 6, 2025
Patient Considerations when Using Ritlecitinib for Alopecia Areata in Adolescents: Guidance for the CliniciansLi-Chi Chen, Chino Ogbutor, Kristen J Kelley, et al.
Clinical and Experimental Dermatology|May 14, 2025
Uterine and ovarian pathologies among patients with lichen planopilaris and frontal fibrosing alopeciaChino Ogbutor, Li-Chi Chen, Kristen J Kelley, et al.
Journal of the American Academy of Dermatology|February 21, 2025
Response to Coppinger et al., Comment on "5α-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study"Li-Chi Chen, Tina Yi Jin Hsieh, Aubrey Martin, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Dermatology|November 17, 2024
Response to Truel J. et al's "Response to 'Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia'"Li-Chi Chen, Aubrey Martin, Maryanne M Senna
Archives of Dermatological Research|July 5, 2024
Top 20 dermatologic conditions affecting adult patients of color in the United States: insights from an All of Us Database analysisLi-Chi Chen, Sharon Kam, Hye Jin Chung
Cells|October 23, 2021
Modulation of Inherent Niches in 3D Multicellular MSC Spheroids Reconfigures Metabolism and Enhances Therapeutic PotentialLi-Chi Chen, Hsin-Wen Wang, Chieh-Cheng Huang
World Journal of Psychiatry|December 26, 2014
Polydipsia, hyponatremia and rhabdomyolysis in schizophrenia: A case reportLi-Chi Chen, Ya-Mei Bai, Meng-Han Chang
Journal of the American Academy of Dermatology|February 2, 2025
Discrepancies in patch testing timing and outcomes: A retrospective analysis of the Pediatric Allergic Contact Dermatitis RegistryMykayla Sandler, Eun Jae Kim, Li-Chi Chen, et al.
Journal of the American Academy of Dermatology|October 23, 2024
5α-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort studyLi-Chi Chen, Tina Yi Jin Hsieh, Maryanne M Senna
Journal of the American Academy of Dermatology|February 4, 2024
Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopeciaLi-Chi Chen, Chino Ogbutor, Kristen J Kelley, et al.
Skin Appendage Disorders|June 6, 2025
Patient Considerations when Using Ritlecitinib for Alopecia Areata in Adolescents: Guidance for the CliniciansLi-Chi Chen, Chino Ogbutor, Kristen J Kelley, et al.
Clinical and Experimental Dermatology|May 14, 2025
Uterine and ovarian pathologies among patients with lichen planopilaris and frontal fibrosing alopeciaChino Ogbutor, Li-Chi Chen, Kristen J Kelley, et al.
Journal of the American Academy of Dermatology|February 21, 2025
Response to Coppinger et al., Comment on "5α-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study"Li-Chi Chen, Tina Yi Jin Hsieh, Aubrey Martin, et al.
Pageof 10